After suspecting manipulated results in clinical trials for simufilam, an Alzheimer’s drug, by Hoau-Yan Wang, PhD, a neuroscience professor at the City College of New York, the City University of New York announced Oct. 27 it is conducting an investigation into the professor’s research process. While that investigation is ongoing, the investigation into Dr. Wang’s research is on hold, a spokesperson confirmed to Becker’s.
